Neurodegenerative Diseases Drugs Market Expands at 7.2% CAGR and Hit USD 62,786.2 Million by 2026; Biogen and F. Hoffmann-La Roche Ltd Cover More than Half of the Share: Fortune Business Insights
12 nov. 2020 02h52 HE
|
Fortune Business Insights
Pune, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market size is expected to derive growth from the rising prevalence of neurodegenerative diseases especially among...
Neurodegenerative Diseases Drugs Market to Exhibit 7.2% CAGR till 2026; Rising Geriatric Population to Aid Growth: Fortune Business Insights™
28 mai 2020 10h19 HE
|
Fortune Business Insights
Pune, May 28, 2020 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market is likely to gain traction from the rising incidence of neurodegenerative diseases worldwide. Such diseases...